INCRUSE ELLIPTA

Google image searchProduct monograph

Active ingredient

umeclidinium (umeclidinium bromide), 62.5 MCG/ACT

DIN: 02423596

Dosage form(s): POWDER

Route(s) of administration: INHALATION

Description: POWDER FOR ORAL INHALATION

Schedule: Prescription

Company: GLAXOSMITHKLINE INC

Date: 27-APR-2015

ATC:

• R03 — DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES (ATC, ATC/DDD, )
• R03B — OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS (ATC, ATC/DDD)
• R03BB — Anticholinergics (ATC, ATC/DDD)
• R03BB07 — UMECLIDINIUM BROMIDE (ATC/DDD)

External Links for Incruse Ellipta

Search on Google

• Incruse Ellipta side effects
• Incruse Ellipta dosage
• umeclidinium side effects
• umeclidinium dosage

Glaxosmithkline Inc

Go to GlaxoSmithKline website to see drug product details. Sometimes you can find incruse ellipta photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.